Publication | Closed Access
Novel 1,3,5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: synthesis, cytotoxicity, DNA binding, molecular docking and DFT studies
116
Citations
39
References
2021
Year
Molecular DockingMedicinal ChemistryDna BindingEffective Anticancer AgentsMedicinePharmacological AgentOrganic ChemistryPharmacotherapyAnti-cancer AgentHeterocycle ChemistryDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDft StudiesDrug Discovery
The development of new 1,3,5-triazine-based pyrazole derivatives as effective anticancer agents.
| Year | Citations | |
|---|---|---|
Page 1
Page 1